Hemagglutination Inhibition Antibody Titers as Mediators of Influenza Vaccine Efficacy Against Symptomatic Influenza A(H1N1), A(H3N2), and B/Victoria Virus Infections
The Journal of Infectious Diseases · 25.07.2024 · 230 (1) · 152-160
DOI: 10.1093/infdis/jiae122 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 07.03.2024. Verfasst von Wey Wen Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Ko…. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Hemagglutination Inhibition Tests, Influenza A Virus, H1N1 Subtype. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, US Centers for Disease Control and Prevention, Research Grants Council.
Abstract (Originalsprache)
Background
The hemagglutination inhibition antibody (HAI) titer contributes only a part of vaccine-induced protection against influenza virus infections. Using causal mediation analysis, we quantified the proportion of vaccine efficacy mediated by postvaccination HAI titers.
Methods
We conducted causal mediation analyses using data from a randomized, active-comparator controlled, phase III, trial of an inactivated, split-virion seasonal quadrivalent influenza vaccine in children conducted from October 2010 to December 2011 in 8 countries. Vaccine efficacy was estimated using a weighted Cox proportional hazards model. Estimates were decomposed into the direct and indirect effects mediated by postvaccination HAI titers.
Results
The proportions of vaccine efficacy mediated by postvaccination HAI titers were estimated to be 22% (95% confidence interval, 18%–47%) for influenza A(H1N1), 20% (16%–39%) for influenza A(H3N2), and 37% (26%–85%) for influenza B/Victoria.
Conclusions
HAI titers partially mediate influenza vaccine efficacy against influenza A(H1N1), A(H3N2), and B/Victoria. Our estimates were lower than in previous studies, possibly reflecting expected heterogeneity in antigenic similarity between vaccine and circulating viruses across seasons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
- Laboratory of Data Discovery for Health Limited, Hong Kong Science and Technology Park, New Territories, Hong Kong SAR, China.
- Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
- HKU-Pasteur Research Pole, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
- WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, and Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne,…
- Department of Epidemiology, University of California, California, Los Angeles, USA.
ORCID-Profile: Benjamin J Cowling
Förderung
- NIAID NIH HHS
- US Centers for Disease Control and Prevention
- Research Grants Council
- RGC Senior Research Fellow Scheme
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Lim, W. W., Feng, S., Wong, S. S., Sullivan, S. G., & Cowling, B. J. (2024). Hemagglutination Inhibition Antibody Titers as Mediators of Influenza Vaccine Efficacy Against Symptomatic Influenza A(H1N1), A(H3N2), and B/Victoria Virus Infections. The Journal of Infectious Diseases, 230(1), 152-160. https://doi.org/10.1093/infdis/jiae122
Vancouver
Lim WW, Feng S, Wong SS, Sullivan SG, Cowling BJ. Hemagglutination Inhibition Antibody Titers as Mediators of Influenza Vaccine Efficacy Against Symptomatic Influenza A(H1N1), A(H3N2), and B/Victoria Virus Infections. The Journal of Infectious Diseases. 2024;230(1):152-160. doi:10.1093/infdis/jiae122
BibTeX
@article{Lim2024,
author = {Lim, Wey Wen and Feng, Shuo and Wong, Sook-San and Sullivan, Sheena G and Cowling, Benjamin J},
title = {Hemagglutination Inhibition Antibody Titers as Mediators of Influenza Vaccine Efficacy Against Symptomatic Influenza A(H1N1), A(H3N2), and B/Victoria Virus Infections},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {230},
number = {1},
pages = {152--160},
doi = {10.1093/infdis/jiae122}
}
EUVIMED